ConductScience.org, home

Paper24464643

NTPDase3 and ecto-5'-nucleotidase/CD73 are differentially expressed during mouse bladder cancer progression.

Rockenbach L and 8 others. Purinergic Signal, 2014. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. NTPDase3 and ecto-5'-nucleotidase/CD73 are differentially expressed during mouse bladder cancer progression. Papers, record 24464643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24464643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
NTPDase3 and ecto-5'-nucleotidase/CD73 are differentially expressed during mouse bladder cancer progression.
PubMed
Journal
Purinergic Signal
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
0.7
iCite
Revised in PubMed
2021-10-21
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rockenbach LLiliana
2Braganhol EElizandra
3Dietrich FFabrícia
4Figueiró FFabrício
5Pugliese MManoella
6Edelweiss MIMaria Isabel Albano
7Morrone FBFernanda Bueno
8Sévigny JJean
9Battastini AMAna Maria Oliveira

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
5'-NucleotidaseMajor topic
Disease ProgressionMajor topic
Gene Expression Regulation, NeoplasticMajor topic
PyrophosphatasesMajor topic
Urinary Bladder NeoplasmsMajor topic
Animals
Male
Mice
Mice, Inbred BALB C

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Canadian Institutes of Health ResearchCanadaPubMed

Source PubMed

Download CSV of grants

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118636315The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation.Mol Cell Biochem2008https://conductscience.org/library/papers/18636315PubMed
223249382Determination of the differential expression of mitochondrial long non-coding RNAs as a noninvasive diagnosis of bladder cancer.BMC Urol2012https://conductscience.org/library/papers/23249382PubMed
323046227Opportunities and challenges for anti-CD73 cancer therapy.Immunotherapy2012https://conductscience.org/library/papers/23046227PubMed
423292999Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumors at diagnosis.Int J Cancer2013https://conductscience.org/library/papers/23292999PubMed
520179192CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.Cancer Res2010https://conductscience.org/library/papers/20179192PubMed
618670642Molecular credentialing of rodent bladder carcinogenesis models.Neoplasia2008https://conductscience.org/library/papers/18670642PubMed
717146560A model of hemorrhagic cystitis induced with acrolein in mice.Braz J Med Biol Res2006https://conductscience.org/library/papers/17146560PubMed
822287455High expression of CD73 as a poor prognostic biomarker in human colorectal cancer.J Surg Oncol2012https://conductscience.org/library/papers/22287455PubMed
917823293Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.Am J Pathol2007https://conductscience.org/library/papers/17823293PubMed
10964550Different susceptibilities of the urinary bladder epithelium of animal species to three nitroso compounds.Gan1976https://conductscience.org/library/papers/964550PubMed
1121858682Involvement of ecto-5'-nucleotidase/CD73 in U138MG glioma cell adhesion.Mol Cell Biochem2012https://conductscience.org/library/papers/21858682PubMed
1220661219Extracellular adenosine triphosphate and adenosine in cancer.Oncogene2010https://conductscience.org/library/papers/20661219PubMed
1315565330Immunotherapy for superficial bladder cancer.Cancer Immunol Immunother2005https://conductscience.org/library/papers/15565330PubMed
1421533188Expression and distribution of ectonucleotidases in mouse urinary bladder.PLoS One2011https://conductscience.org/library/papers/21533188PubMed
1520080644Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20080644PubMed
1619513500Anti-tumor effect of cimetidine via inhibiting angiogenesis factors in N-butyl-N-(4-hydroxybutyl) nitrosamine-induced mouse and rat bladder carcinogenesis.Oncol Rep2009https://conductscience.org/library/papers/19513500PubMed
1715247774Characteristics of adenosine triphosphate [corrected] release from porcine and human normal bladder.J Urol2004https://conductscience.org/library/papers/15247774PubMed
1819372055Differential ectonucleotidase expression in human bladder cancer cell lines.Urol Oncol2010https://conductscience.org/library/papers/19372055PubMed
1917671792Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells.J Cancer Res Clin Oncol2008https://conductscience.org/library/papers/17671792PubMed
2023176070Purinergic signalling in the lower urinary tract.Acta Physiol (Oxf)2013https://conductscience.org/library/papers/23176070PubMed

See all 61 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
42014997ENTPD3 as a novel regulator of endometrial receptivity: suppressing EMT via the ATP-P2Y2 axis in patients with recurrent implantation failure.Cell Mol Biol Lett2026https://conductscience.org/library/papers/42014997PubMed
40232523Evaluation of hepatic cancer stem cells (CD73+, CD44+, and CD90+) induced by diethylnitrosamine in male rats and treatment with biologically synthesized silver nanoparticles.Mol Biol Rep2025https://conductscience.org/library/papers/40232523PubMed
39567465Expression and Hormonal Regulation of Entpd3 at Various Estrous Cycle Stages in the Mouse Uterus.Reprod Sci2025https://conductscience.org/library/papers/39567465PubMed
37906424Preclinical evaluation of bozepinib in bladder cancer cell lines: modulation of the NPP1 enzyme.Purinergic Signal2025https://conductscience.org/library/papers/37906424PubMed
36964277Characterization of purinergic signaling in tumor-infiltrating lymphocytes from lower- and high-grade gliomas.Purinergic Signal2024https://conductscience.org/library/papers/36964277PubMed
36676954Urinary ATP Levels Are Controlled by Nucleotidases Released from the Urothelium in a Regulated Manner.Metabolites2022https://conductscience.org/library/papers/36676954PubMed
35429327High P2X6 receptor expression in human bladder cancer predicts good survival prognosis.Mol Cell Biochem2022https://conductscience.org/library/papers/35429327PubMed
35079944Structure-activity features of purines and their receptors: implications in cell physiopathology.Mol Biomed2022https://conductscience.org/library/papers/35079944PubMed
34381563High CD39 expression is associated with the non-muscle-invasive phenotype of human bladder cancer.Oncotarget2021https://conductscience.org/library/papers/34381563PubMed
33879578Ectonucleotidases in Inflammation, Immunity, and Cancer.J Immunol2021https://conductscience.org/library/papers/33879578PubMed
31754326GATA Binding Protein 3 Boosts Extracellular ATP Hydrolysis and Inhibits Metastasis of Breast Cancer by Up-regulating Ectonucleoside Triphosphate Diphosphohydrolase 3.Int J Biol Sci2019https://conductscience.org/library/papers/31754326PubMed
31698766Impaired Expression of Ectonucleotidases in Ectopic and Eutopic Endometrial Tissue Is in Favor of ATP Accumulation in the Tissue Microenvironment in Endometriosis.Int J Mol Sci2019https://conductscience.org/library/papers/31698766PubMed
29663369Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.Int J Cancer2018https://conductscience.org/library/papers/29663369PubMed
29305710Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.J Cancer Res Clin Oncol2018https://conductscience.org/library/papers/29305710PubMed
29184552Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives.Front Immunol2017https://conductscience.org/library/papers/29184552PubMed
26543299CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer.Dis Markers2015https://conductscience.org/library/papers/26543299PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24464643

GET https://conductscience.org/api/papers/v1/24464643/references?page=2